Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Medtronic
Mallinckrodt
Dow
Moodys

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR DESYREL


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Desyrel

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00027053 ↗ Trazodone for Sleep Disturbance in Early Alcohol Recovery Completed National Institute on Alcohol Abuse and Alcoholism (NIAAA) Phase 2 2002-06-01 This study is a randomized, double-blind clinical trial comparing trazodone (Desyrel) and placebo among sleep-disturbed, alcohol-dependent individuals shortly after discharge from an inpatient detoxification program. Subjects will undergo a baseline assessment and random assignment to trazodone or identical placebo for 12 weeks. All persons completing the alcohol detoxification at Stanley Street Treatment and Resources (SSTAR) will be screened. (SSTAR of Rhode Island provides detoxification services to non/underinsured persons of Rhode Island.)
NCT00027053 ↗ Trazodone for Sleep Disturbance in Early Alcohol Recovery Completed Rhode Island Hospital Phase 2 2002-06-01 This study is a randomized, double-blind clinical trial comparing trazodone (Desyrel) and placebo among sleep-disturbed, alcohol-dependent individuals shortly after discharge from an inpatient detoxification program. Subjects will undergo a baseline assessment and random assignment to trazodone or identical placebo for 12 weeks. All persons completing the alcohol detoxification at Stanley Street Treatment and Resources (SSTAR) will be screened. (SSTAR of Rhode Island provides detoxification services to non/underinsured persons of Rhode Island.)
NCT00253890 ↗ Insomnia and Drug Relapse Risk Completed National Institute on Drug Abuse (NIDA) Phase 3 2005-10-01 The purposes of this study are: 1. to evaluate the relationship between subjective complaints of sleep and objective measures of sleep quality, as measured through polysomnography, and 2. to evaluate the efficacy of trazodone, as compared to placebo, in individuals early in methadone maintenance.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Desyrel

Condition Name

Condition Name for Desyrel
Intervention Trials
Healthy 3
Insomnia 3
Sleep Bruxism 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Desyrel
Intervention Trials
Sleep Initiation and Maintenance Disorders 5
Parasomnias 3
Sleep Wake Disorders 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Desyrel

Trials by Country

Trials by Country for Desyrel
Location Trials
United States 17
Canada 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Desyrel
Location Trials
California 2
Pennsylvania 2
Rhode Island 2
Maryland 1
Virginia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Desyrel

Clinical Trial Phase

Clinical Trial Phase for Desyrel
Clinical Trial Phase Trials
Phase 4 5
Phase 3 2
Phase 2 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Desyrel
Clinical Trial Phase Trials
Completed 4
Not yet recruiting 3
Terminated 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Desyrel

Sponsor Name

Sponsor Name for Desyrel
Sponsor Trials
Labopharm Inc. 2
National Institute on Aging (NIA) 2
Butler Hospital 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Desyrel
Sponsor Trials
Other 15
NIH 6
Industry 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Dow
Moodys
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.